Re-appointment of Mr. Umang Gosalia as a Managing Director of the Company
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Parmax Pharma Ltd has announced the re-appointment of Dr. Umang Gosalia as Managing Director for another 5-year term starting June 28, 2026 till June 27, 2031. The appointment is subject to shareholder approval at the upcoming AGM/EGM. Dr. Gosalia holds a Ph.D. in Organic Chemistry and has over 1.5 decades of experience in chemistry and production activities. He has been associated with the company since 2016 and is currently responsible for all production activities. The board's Nomination and Remuneration Committee recommended this re-appointment, which was approved at the board meeting held on May 02, 2026.
This is a routine corporate governance update ensuring leadership continuity at Parmax Pharma. The re-appointment of an experienced Managing Director with a long tenure is generally positive for operational stability. No immediate impact on stock price expected as this is a continuation of existing leadership subject to standard shareholder approval.